Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR™)

Sponsored by Anteris

Summary

Join this discussion between Christopher Meduri, Susheel Kodali and João Cavalcante covering the early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve called DurAVR™.

This video was recorded for EuroPCR 2023. View more videos and interviews here